Absci CORP (ABSI) — 10-K Filings
All 10-K filings from Absci CORP. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Absci's AI-Driven Drug Platform Accelerates Development, Targets $303.8M Market
— Mar 24, 2026 Risk: high
Absci Corp (ABSI) is a clinical-stage biopharmaceutical company leveraging an AI-native platform for antibody therapeutics. The company has demonstrated capital -
Absci Corp Files 2024 10-K
— Mar 18, 2025 Risk: medium
Absci Corp filed its 2024 10-K on March 18, 2025, reporting its fiscal year ending December 31, 2024. The company, headquartered in Vancouver, WA, operates in t -
Absci Corp Files 2023 Annual Report (10-K)
— Mar 21, 2024 Risk:
Absci Corp (ABSI) filed a Annual Report (10-K) with the SEC on March 21, 2024. Absci Corp filed its 10-K report for the fiscal year ending December 31, 2023. Th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX